Synthesis and Biological Evaluation of Bicyclic Nucleosides as Inhibitors of M. tuberculosis Thymidylate Kinase
Citations Over TimeTop 24% of 2006 papers
Abstract
Herein we describe the synthesis and conformational analysis of a series of bicyclic thymidine derivatives and their evaluation as inhibitors of thymidine monophosphate kinase from Mycobacterium tuberculosis (TMPKmt), based on previously discovered bicyclic sugar nucleosides. With a K(i) value of 2.3 microm, 1-[3-aminomethyl-3,5-dideoxy-2-O,6-N-(thiocarbonyl)-beta-D-ribofuranosyl]thymine emerged as the most potent TMPK inhibitor of this series. Moreover, this promising compound displays inhibitory potency against Mycobacteria cultures with an IC(99) value of 100 microg mL(-1), thus promoting TMPKmt for the first time as a validated target for further inhibitory design. Attempts to rationalise the observed structure-activity relationship (SAR) involving molecular modelling and conformational analysis are described.
Related Papers
- → Thymidine uptake, thymidine incorporation, and thymidine kinase activity in marine bacterium isolates(1990)36 cited
- → Phosphorylation of tritiated thymidine by L929 mouse fibroblasts(1969)68 cited
- → A comparison of the utilization of thymine and thymidine for the synthesis of DNA-thymine in novikoff hepatoma cells(1974)9 cited
- → The effects of fluorouracil on thymidylate synthase and thymidine kinase in regenerating rat liver after partial hepatectomy(1991)7 cited
- → Interconversion of thymine and thymidine in a thymine requiring strain of Bacillus subtilis(1975)2 cited